Class II recall: Mallinckrodt Hospital Products Inc.: Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Onl
Mallinckrodt Hospital Products Inc. issued a Class II recall of Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vials, NDC 63004-8710-1 and 63004-8710-2. The recall notice states the reason is presence of particulate matter, identified as glass and stopper piece, within the vials.
Most relevant for: Patients currently using or prescribed Acthar Gel repository corticotropin injection from the affected lot and NDC numbers.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More allergy & immunology updates
- Allergic-like reactions to mRNA vaccines occurred only in high-risk groupOct 13, 2026
- Oral deucrictibant speeds symptom relief in HAE attacks, trial findsOct 8, 2026
- PGE2 signaling found to modulate MRGPRX2-mediated anaphylaxis severitySep 30, 2026
- Registry data compare rapamycin and leniolisib in APDSSep 28, 2026
- Mepolizumab linked to sustained airway remodeling benefits at 3 yearsSep 28, 2026